» Articles » PMID: 30309972

Interventions to Improve Retention-in-care and Treatment Adherence Among Patients with Drug-resistant Tuberculosis: a Systematic Review

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2018 Oct 13
PMID 30309972
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The global loss to follow-up (LTFU) rate among drug-resistant tuberculosis (DR-TB) patients remains high at 15%. We conducted a systematic review to explore interventions to reduce LTFU during DR-TB treatment.We searched for studies published between January 2000 and December 2017 that provided any form of psychosocial or material support for patients with DR-TB. We estimated point estimates and 95% confidence intervals of the proportion LTFU. We performed subgroup analyses and pooled estimates using an exact binomial likelihood approach.We included 35 DR-TB cohorts from 25 studies, with a pooled proportion LTFU of 17 (12-23)%. Cohorts that received any form of psychosocial or material support had lower LTFU rates than those that received standard care. Psychosocial support throughout treatment, counselling sessions or home visits, was associated with lower LTFU rates compared to when support was provided through a limited number of visits or not at all.Our review suggests that psychosocial support should be provided throughout DR-TB treatment in order to reduce treatment LTFU. Future studies should explore the potential of providing self-administered therapy complemented with psychosocial support during the continuation phase.

Citing Articles

Patients' acceptability, adherence and satisfaction on the modified shorter all-oral multidrug-resistant tuberculosis regimen: a two-phase cross-sectional study in Tanzania.

Lalashowi J, Mvungi H, Mwaisango Z, Pamba D, Mohamed A, Gitige C BMJ Open. 2025; 15(3):e088556.

PMID: 40037680 PMC: 11881200. DOI: 10.1136/bmjopen-2024-088556.


Interventions and implementation considerations for reducing pre-treatment loss to follow-up in adults with pulmonary tuberculosis: A scoping review.

Mulaku M, Owino E, Ochodo E, Young T F1000Res. 2025; 13:1436.

PMID: 39816981 PMC: 11733733. DOI: 10.12688/f1000research.157439.1.


The effect of the peer support intervention on internalized stigma among Thai patients with tuberculosis: A repeated measures design.

Vibulchai N, Dana K, Sanchan M, Churari C, Jadboonnak B, Sawangsri W Belitung Nurs J. 2024; 10(4):408-415.

PMID: 39211457 PMC: 11350345. DOI: 10.33546/bnj.3327.


Concomitant bedaquiline and delamanid therapy in patients with drug-resistant extra-pulmonary tuberculosis in Mumbai, India.

Mongia H, Mamnoon F, Silsarma A, Mahajan R, Dalal A, Galindo M J Clin Tuberc Other Mycobact Dis. 2024; 35:100433.

PMID: 38617837 PMC: 11015490. DOI: 10.1016/j.jctube.2024.100433.


Self-driven solutions and resilience adapted by people with drug-resistant tuberculosis and their caregivers in Bengaluru and Hyderabad, India: a qualitative study.

Nagarajan K, Kumarswamy K, Begum R, Panibatla V, Singarajipura A, Adepu R Lancet Reg Health Southeast Asia. 2024; 22:100372.

PMID: 38420270 PMC: 10900834. DOI: 10.1016/j.lansea.2024.100372.